Improvement in hypertension management in England: results from the Health Survey for England 2003

Primatesta, Paola; Poulter, Neil

doi:10.1097/01.hjh.0000226210.95936.bc

Cited by 199 publications

(208 citation statements)

References 12 publications

Supporting

Mentioning

178

Contrasting

Unclassified

Order By: Relevance

“…17 In particular, the lack of improvement in SBP may prevent the patients to receive the benefits of otherwise improved hypertension care. Compared with the prevalences of hypertension in our study, those reported since 2000 in other studies by age and sex have been lower in most, [18][19][20][21][22][23][24][25][26][27] but not in all populations. 27,28 As in our paper, the rate of awareness of hypertension in these reports was usually more than 60%.…”

Section: Discussioncontrasting

confidence: 90%

Despite evidence-based guidelines, systolic blood pressure remains inadequately controlled in older hypertensive adults

Antikaínen

Kastarinen

Jousilahti³

et al. 2009

J Hum Hypertens

View full text Add to dashboard Cite

We aimed to assess the trends in the prevalence, awareness, treatment and control of hypertension in Finnish men and women aged 60-74 years. Three independent cross-sectional population surveys were conducted in 1997, 2002 and 2007 remained stable. The mean diastolic blood pressure (BP) decreased in both genders. Awareness of hypertension increased from 60 to 71% in men (Po0.001 for trend) and from 66 to 76% (P ¼ 0.012) in women. The prevalence of antihypertensive drug treatment among hypertensive people increased from 35 to 56% in both genders (Po0.001). The proportion of treated hypertensive patients with adequately controlled BP increased from 16 to 32% in men (Po0.001) and from 16 to 30% in women (P ¼ 0.003). Hypertension care in older adults has improved in Finland during 1997 to 2007. The situation is not optimal: the main problem in this age group is high SBP.

show abstract

Section: Discussioncontrasting

confidence: 90%

Despite evidence-based guidelines, systolic blood pressure remains inadequately controlled in older hypertensive adults

Antikaínen

Kastarinen

Jousilahti³

et al. 2009

J Hum Hypertens

View full text Add to dashboard Cite

show abstract

“…In fact, the recently published report of the 2003 HSE revealed that the number of patients on X2 antihypertensive agents had increased to 56% since 1998. 39 In view of the results of the present study, future guidelines may need to focus on encouraging the initiation and continuation of antihypertensive therapy, to ensure that all hypertensive patients are adequately treated.…”

Section: Treatment Of Hypertensive Patients With X3 Additional Risk Fmentioning

confidence: 93%

“…42 Risk estimating systems such as SCORE are increasingly important considering the overall failure of medical practice to achieve substantial reductions in cardiovascular risk in Europe. 39,[44][45][46][47][48] This study demonstrates that dyslipidaemia may often go unrecognized in hypertensive individuals. Moreover, our results indicate a significant gap between treatment guidelines and actual clinical practice.…”

Section: Treatment Of Hypertensive Patients With X3 Additional Risk Fmentioning

confidence: 99%

Treatment patterns of hypertension and dyslipidaemia in hypertensive patients at higher and lower risk of cardiovascular disease in primary care in the United Kingdom

2007

View full text Add to dashboard Cite

Few studies have investigated the presence of dyslipidaemia in hypertensive individuals. In addition, few data exist on the concurrent treatment of both conditions for the prevention of cardiovascular disease (CVD). This retrospective cohort study examined treatment patterns for hypertension and dyslipidaemia among hypertensive patients in UK primary care. We defined a population of patients aged X40 years from the UK General Practice Research Database. Hypertensive individuals with X3 additional cardiovascular risk factors (ARFs) were compared with a cohort comprising hypertensive patients with p2 ARFs. We analysed the prevalence of risk factors and the prevalence and incidence of treatment for hypertension, dyslipidaemia and for both conditions between January 1997 and December 2001. A total of 117 840 hypertensive patients were identified (23 655 with X3 ARFs, 94 185 with p2 ARFs) in 1997; in 2001, the number diagnosed as hypertensive was 133 683 (40 248 X3 ARFs, 93 435 p2 ARFs). The prevalence of antihypertensive treatment in the hypertensive patients with X3 ARFs increased during the study. In 2001, approximately one-third of hypertensive patients with X3 ARFs were not receiving antihypertensives. Among those patients who received such treatment, the majority received X2 separate agents in accordance with current guidelines. Treatment for concurrent hypertension and dyslipidaemia was initiated in o8% of patients with hypertension and X3 ARFs in each year. These findings demonstrate the under-recognition/undertreatment of cardiovascular risk factors in UK primary care among patients at risk of CVD.

show abstract

“…Large patient studies in industrialized countries have found relatively low proportions (27-34%) of hypertensive patients with fully controlled BP, although a few surveys do show better results (48-63%). [18][19][20][21][22][23][24][25] Quantitative data on BP control among hypertensive patients treated in middle-and lowincome countries are more limited and certainly no better (19.5-44.4%). [26][27][28][29][30][31] A recent systematic review of the literature found no significant differences in mean prevalence, awareness, treatment and control of hypertension between developing and developed countries.…”

Section: Discussionmentioning

confidence: 99%

Treatment of hypertension in rural Cambodia: results from a 6-year programme

Isaakidis¹,

Raguenaud²,

Say

et al. 2010

J Hum Hypertens

View full text Add to dashboard Cite

This study was aimed to describe the outcomes of a hypertension treatment programme in two outpatient clinics in Cambodia. We determined proportions of patients who met the optimal targets for blood pressure (BP) control and assessed the evolution of mean systolic and diastolic BP (SBP/DBP) over time. Multivariate analyses were used to identify predictors of BP decrease and risk factors for LTFU. A total of 2858 patients were enrolled between March 2002 and June 2008 of whom 69.2% were female, 30.5% were aged X64years and 32.6% were diabetic. The median follow-up time was 600 days. By the end of 2008, 1642 (57.4%) were alive-in-care, 8 (0.3%) had died and 1208 (42.3%) were lost to follow-up. On admission, mean SBP and DBP were 162 and 94 mm Hg, respectively. Among the patients treated, a significant SBP reduction of 26.8 mm Hg (95% CI:28.4-25.3) was observed at 6 months. Overall, 36.5% of patients reached the BP targets at 24 months. The number of young adults, non-overweight patients and non-diabetics reaching the BP targets was more. Older age (464 years), uncontrolled DBP (X90 mm Hg) on last consultation and coming late for the last consultation were associated with LTFU, whereas non-diabetic patients were 1.5 times more likely to default than diabetics (95% CI: 1.3-1.7). Although the definite magnitude of the BP decrease due to antihypertension medication over time cannot be assessed definitely without a control group, our results suggest that BP reduction can be obtained with essential hypertension treatment in a large-scale programme in a resource-limited setting.

show abstract

Improvement in hypertension management in England: results from the Health Survey for England 2003

Abstract: Hypertension management has improved greatly since 1994, with more awareness, treatment and control. Nevertheless, in 2003 the majority of hypertensive adults in England had blood pressure levels above the currently recommended targets.

Cited by 199 publications

References 12 publications

Despite evidence-based guidelines, systolic blood pressure remains inadequately controlled in older hypertensive adults

Despite evidence-based guidelines, systolic blood pressure remains inadequately controlled in older hypertensive adults

Treatment patterns of hypertension and dyslipidaemia in hypertensive patients at higher and lower risk of cardiovascular disease in primary care in the United Kingdom

Treatment of hypertension in rural Cambodia: results from a 6-year programme

Contact Info

Product

Resources

About